Search

everythinglearnresearchcommunity

for

Search:↓

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

CTIP2 may help in skin development and maintenance.

The treatment is safe and shows promise for metastatic breast cancer.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

C-reactive protein helps monocytes stick to blood vessel cells by causing oxidative stress.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Reflectance confocal microscopy is a useful, non-invasive tool for diagnosing some skin diseases, with potential for future improvements.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

The topical treatment WR 279,396 effectively healed cutaneous leishmaniasis in mice without relapse.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

A woman with severe angioedema improved significantly after treatment with rituximab.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

Cabergoline helped a boy with Cushing disease get better after surgery and radiotherapy didn't work.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Cardiomyocyte-derived media can inhibit lung cancer cell growth and movement.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.